Content has been extensively re-written to better adhere to the principles of the AMA Guides, Sixth Edition by promoting the concept of Diagnosis Based Impairment. The structure of the chapter has changes and the way impairment ratings are performed has changed as well.
Synopses of changes include, but are not limited to:
This page is designed to provide you with easy access to the AMA Guides to the Evaluation of Permanent Impairment 6th Edition, 2023 tables.
Jump to Chapter:
Chapter 1: Conceptual Foundations and Philosophy |
---|
Tables |
Table 1-1: Self-Care |
Table 1-2: Hierarchy of Study Types |
Table 1-3: ICF Codes and Functional Levels |
Table 1-4: Sample Impairment Function Classification |
Table 1-5: Generic Template for Impairment Classification Grids |
Table 1-6: General Principles for Calculating Impairment |
Chapter 2: Practical Application of the Guides |
Tables |
Table 2-1: Fundamental Principles of the Guides |
Chapter 3: Pain-Related Impairment |
Tables |
Table 3-1: Pain-Related Impairment and Whole Person Impairment Based on Pain Disability Questionnaire |
Chapter 4: The Cardiovascular System |
Tables |
Table 4-1: NYHA Functional Classification of Cardiac Disease |
Table 4-2: Relationship of METs and Functional Class According to 5 Treadmill Protocols |
Table 4-3: Energy Expenditure in METs During Bicycle Ergometry |
Table 4-4: Methodology for Determining the Grade in an Impairment Class |
Table 4-5: Criteria for Rating Permanent Impairment due to Valvular Heart Disease |
Table 4-6: Criteria for Rating Impairment due to Coronary Artery Disease |
Table 4-7: Criteria for Rating Impairment due to Cardiomyopathies |
Table 4-8: Criteria for Rating Impairment due to Pericardial Heart Disease |
Table 4-9: Criteria for Rating Impairment due to Dysrhythmias |
Table 4-10: Classification of Blood Pressure for Adults |
Table 4-11: Criteria for Rating impairment due to Hypertensive Cardiovascular Disease |
Table 4-12: Criteria for Rating Impairment due to Peripheral Vascular Disease – Lower Extremity |
Table 4-13: Criteria for Rating Impairment due to Peripheral Vascular Disease – Upper Extremity |
Table 4-14: Criteria for Rating Impairment due to Diseases of the Pulmonary Artery |
Table 4-15: Cardiac Impairment Evaluation Summary |
Chapter 5: The Pulmonary System |
Tables |
Table 5-1: Impairment Classification of Dyspnea (Adapted) |
Table 5-2: Impairment Classification for Prolonged Physical Work Intensity by Oxygen Consumption |
Table 5-3: Methodology for Determining the Grade in an Impairment Class |
Table 5-4: Criteria for Rating Permanent Impairment due to Pulmonary Dysfunction |
Table 5-5: Criteria for Rating Permanent Impairment due to Asthma |
Table 5-6: Scale for Judging Capabilities of Subjects With Cancer |
Table 5-7: Pulmonary Impairment Evaluation Summary |
Chapter 6: The Digestive System |
Tables |
Table 6-1: Desirable Weights for Men by Height and Body Build |
Table 6-2: Desirable Weights for Women by Height and Body Build |
Table 6-3: Methodology for Determining the Grade in an Impairment Class |
Table 6-4: Criteria for Rating Permanent Impairment due to Upper Digestive Tract (Esophagus, Stomach and Duodenum, Small Intestine, and Pancreas) Disease |
Table 6-5: Criteria for Rating Permanent Impairment due to Colonic and Rectal Disorders |
Table 6-6: Criteria for Rating Permanent Impairment due to Anal Disease |
Table 6-7: Impairments From Surgically Created Stomas |
Table 6-8: Criteria for Rating Permanent Impairment due to Liver Disease |
Table 6-9: Criteria for Rating Permanent Impairment due to Biliary Tract Disease |
Table 6-10: Criteria for Rating Permanent Impairment due to Herniation |
Table 6-11: Digestive System Impairment Evaluation Summary |
Chapter 7: The Urinary and Reproductive Systems |
Tables |
Table 7-1: Methodology for Determining the Grade in an Impairment Class |
Table 7-2: Criteria for Rating Permanent Impairment due to Upper Urinary Tract Disease |
Table 7-3: Criteria for Rating Permanent Impairment due to Urinary Diversion Disorders |
Table 7-4: Criteria for Rating Permanent Impairment due to Bladder Disease |
Table 7-5: Criteria for Rating Permanent Impairment due to Urethral Disease |
Table 7-6: Criteria for Rating Permanent Impairment due to Penile Disease |
Table 7-7: Criteria for Rating Permanent Impairment due to Scrotal Disease |
Table 7-8: Criteria for Rating Impairment due to Testicular, Epididymal, and Spermatic Cord Disease |
Table 7-9: Criteria for Rating Impairment due to Prostate Disease |
Table 7-10: Criteria for Rating Permanent Impairment due to Vulval and Vaginal Disease |
Table 7-11: Criteria for Rating Permanent Impairment due to Cervical and Uterine Disease |
Table 7-12: Criteria for Rating Permanent Impairment due to Fallopian Tube and Ovarian Disease |
Table 7-13: Urinary and Reproductive Systems Impairment Evaluation Summary |
Chapter 8: The Skin |
Tables |
Table 8-1: Structure, Functions, and Disorders of the Skin |
Table 8-2: Criteria for Rating Permanent Impairment due to Skin Disorders |
Table 8-3: Skin Impairment Evaluation Summary |
Chapter 9: The Hematopoietic System |
Tables |
Table 9-1: Karnofsky Performance Status Scale Definitions Rating (%) Criteria |
Table 9-2: Eastern Cooperative Oncology Group Performance Status Scale (ECOG-PSS) |
Table 9-3: Burden of Treatment Compliance |
Table 9-4: Methodology for Determining the Grade in an Impairment Class |
Table 9-5: Criteria for Rating Permanent Impairment due to Anemia |
Table 9-6: Criteria for Rating Permanent Impairment due to Neutropenia |
Table 9-7: Criteria for Rating Permanent Impairment due to the Leukemias |
Table 9-8: Criteria for Rating Permanent Impairment due to HIV Disease |
Table 9-9: Criteria for Rating Impairment due to Platelet Disorders |
Table 9-10: Criteria for Rating Impairment due to the Hemophilias |
Table 9-11: Criteria for Rating Impairment due to Other Bleeding Disorders |
Table 9-12: Criteria for Rating Impairment due to Thrombotic Disorders |
Table 9-13: Criteria for Rating Impairment due to Lymphoma and Metastatic Disease |
Table 9-14: Hematologic Impairment Evaluation Summary |
Chapter 10: The Endocrine System |
Tables |
Table 10-1: Methodology for Determining the Grade in an Impairment Class |
Table 10-2a: Enteral, Intranasal, and Topical Medications |
Table 10-2b: Parenteral Medications |
Table 10-3: Points Assigned for Dietary Modification |
Table 10-4: Procedure-Based Points |
Table 10-5: Criteria for Rating Impairment due to Disorders of the Hypothalamic-Pituitary Axis |
Table 10-6: Criteria for Rating Impairment due to Thyroid Abnormalities |
Table 10-7: Criteria for Rating Impairment due to Disorders of the Parathyroids |
Table 10-8: Criteria for Rating Impairment due to Disorders of the Adrenal Cortex |
Table 10-9: Criteria for Rating Impairment due to Disorders of the Adrenal Medulla |
Table 10-10: Criteria for Rating Impairment due to Diabetes Mellitus |
Table 10-11: Criteria for Rating Impairment due to Hypoglycemia |
Table 10-12: Criteria for Rating Impairment due to Gonadal Disorders |
Table 10-13: Criteria for Rating Impairment due to Mammary Disorders |
Table 10-14: Criteria for Rating Impairment due to Metabolic Bone Disease |
Table 10-15: Endocrine System Impairment Evaluation Summary |
Chapter 11: Ear, Nose, Throat, and Related Structures |
Tables |
Table 11-1: Monaural Hearing Loss and Impairment |
Table 11-2: Computation of Binaural Hearing Impairment |
Table 11-3: Relationship of Binaural Hearing Impairment to Impairment of the Whole Person |
Table 11-4: Criteria for Rating Impairments due to Vestibular Disorders |
Table 11-5: Criteria for Rating Impairment due to Facial Disorders and/or Disfigurement |
Table 11-6: Criteria for Rating Impairment due to Air Passage Deficits |
Table 11-7: Impairments of Mastication and Deglutition: Relationship of Dietary Restrictions to Permanent Impairment |
Table 11-8: Criteria for Rating Voice and Speech Impairment |
Chapter 12: The Visual System |
Tables |
Table 12-1: Calculation Steps for the Visual System |
Table 12-2: Impairment of Visual Acuity |
Table 12-3: Calculation of the Acuity-Related Impairment Rating |
Table 12-4: Classification of Impairment of Visual Acuity |
Table 12-5: Impairment of Visual Field |
Table 12-6: Conversion of Field Radius to Field Score |
Table 12-7: Calculation of the Visual Field–Related Impairment Rating |
Table 12-8: Classification of Impairment of Visual Field |
Table 12-9: Correction for Central Scotomata |
Table 12-10: Classification of Impairment of the Visual System and of the Whole Person |
Table 12-11: Determination of Reading Acuity and Impairment Rating, Using Letter Size and Viewing Distance |
Chapter 13: The Nervous System |
Tables |
Table 13-1A: Summary of Chapters Used to Rate Various Neurologic Disorders |
Table 13-1B: Activities of Daily Living |
Table 13-1C: Summary of Impairment Rating Tables |
Table 13-1D: Burden of Treatment Compliance |
Table 13-2A: Nervous System Rating Tables |
Table 13-2B: Rating the Effects of a Neurologic Disease |
Table 13-2C: Methods for Rating Neurologic-Based Impairment |
Table 13-2D: Framework for Rating Tables Within This Chapter |
Table 13-3A: Method Specific to Rating Cognitive Cerebral Impairments |
Table 13-3B: Progression of the MSCHIF-E Into Disorders of Consciousness |
Table 13-4 QuickView Worksheet (Master): Summary of Rating Impairment Table |
Table 13-5A: Disorders of Consciousness |
Table 13-5B: Episodic Disorders (Epilepsy and Autonomic Disorders) |
Table 13-5C: Mental Status, Cognition, Highest Integrative Function, and Emotion (MSCHIF-E) |
Table 13-5D Upper Extremity CNS Dysfunction |
Table 13-5E Station and Gait Disorders |
Table 13-5F Neurogenic Respiratory Dysfunction |
Table 13-5G Neurogenic Bowel |
Table 13-5H Neurogenic Bladder |
Table 13-5I Neurogenic Sexual Dysfunction |
Table 13-5J Neuropathic Pain (Peripheral Neuropathy and Craniofacial) |
Table 13-5K Migraine |
Chapter 14: Mental and Behavioral Disorders |
Tables |
Table 14-1: Mental Status Examination |
Table 14-2: Selected Psychological Assessment Tools in Adults |
Table 14-3: Suggestions for the Mental and Behavioral Disorders Independent Medical Examination |
Table 14-4: Functional Impairment Scales for Patients With Mental and Behavioral Disorders (M&BDs) |
Table 14-5: Factors That May Affect Motivation |
Table 14-6: Characteristics Suggestive of the Need to Evaluate for Malingering |
Table 14-7: Brief Psychiatric Rating Scale Form |
Table 14-8: Impairment Score of Brief Psychiatric Rating Scale |
Table 14-9: Self-Care, Personal Hygiene, and Activities of Daily Living |
Table 14-10: Role Functioning, Social and Recreational Activities |
Table 14-11: Travel |
Table 14-12: Interpersonal Relationships |
Table 14-13: Concentration, Persistence, and Pace |
Table 14-14: Resilience and Employability |
Table 14-15: Impairment Score of Psychiatric Impairment Rating Scale |
Chapter 15: The Upper Extremities |
Tables |
Table 15-1: Definition of Impairment Classes |
Table 15-2: Digit Regional Grid: Digit Impairments |
Table 15-3: Wrist Regional Grid: Upper Extremity Impairments |
Table 15-4: Elbow Regional Grid: Upper Extremity Impairments |
Table 15-5: Shoulder Regional Grid: Upper Extremity Impairments |
Table 15-6: Adjustment Grid: Summary |
Table 15-7: Functional History Adjustment: Upper Extremities |
Table 15-8: Physical Examination Adjustment: Upper Extremities |
Table 15-9: Clinical Studies Adjustment: Upper Extremities |
Table 15-10: Methodology for Determining the Grade in an Impairment Class |
Table 15-11: Impairment Values Calculated From Upper Extremity Impairment |
Table 15-12: Impairment Values Calculated From Digit Impairment |
Table 15-13: Monofilament Test Criteria |
Table 15-14: Sensory and Motor Severity |
Table 15-15: Sensory Quality Impairment Classification |
Table 15-16: Digit Impairment for Transverse and Longitudinal Sensory Losses in Thumb and Little Finger Based on Percent of Digital Length Involved |
Table 15-17: Digit Impairment for Transverse and Longitudinal Sensory Losses in Index, Middle, and Ring Fingers Based on Percent of Digital Length Involved |
Table 15-18: Impairment for Sensory Only Peripheral Nerve Injury |
Table 15-19: Origins and Functions of Peripheral Nerves of Upper Extremity Emanating From Brachial Plexus |
Table 15-20: Brachial Plexus Impairment: Upper Extremity Impairments |
Table 15-21: Peripheral Nerve Impairment: Upper Extremity Impairments |
Table 15-22: Activities of Daily Living (ADLs) |
Table 15-23: Entrapment/Compression Neuropathy Impairment |
Table 15-24: Diagnostic Criteria for Complex Regional Pain Syndrome |
Table 15-25: Objective Diagnostic Criteria Points for Complex Regional Pain Syndrome |
Table 15-26: Complex Regional Pain Syndrome (Type I): Upper Extremity Impairments |
Table 15-27: Level of Amputation |
Table 15-28: Impairment for Upper Limb Amputation at Various Levels |
Table 15-29: Amputation Impairment |
Table 15-30: Thumb Range of Motion |
Table 15-31: Finger Range of Motion |
Table 15-32: Wrist Range of Motion |
Table 15-33: Elbow/Forearm Range of Motion |
Table 15-34: Shoulder Range of Motion |
Table 15-35: Range of Motion Grade Modifiers |
Table 15-36: Functional History Grade Adjustment: Range of Motion |
Table 15-37: Activities of Daily Living Questionnaire |
Table 15-38: ADLs Questionnaire Evaluation |
Table 15-39: Comparison Between QuickDASH and ADL Questionnaires |
Table 15-40: Self-Report Functional Assessment Measures |
Chapter 16: The Lower Extremities |
Tables |
Table 16-1: Definition of Impairment Classes |
Table 16-2: Foot and Ankle Regional Grid – Lower Extremity Impairments |
Table 16-3: Knee Regional Grid – Lower Extremity Impairments |
Table 16-4: Hip Regional Grid – Lower Extremity Impairments |
Table 16-5: Adjustment Grid: Summary |
Table 16-6: Functional History Adjustment – Lower Extremities |
Table 16-7: Physical Examination Adjustment – Lower Extremities |
Table 16-8: Clinical Studies Adjustment – Lower Extremities |
Table 16-9: Methodology for Determining the Grade in an Impairment Class |
Table 16-10: Impairment Values Calculated From Lower Extremity Impairment |
Table 16-11: Sensory and Motor Severity |
Table 16-12: Peripheral Nerve Impairment – Lower Extremity Impairments |
Table 16-13: Diagnostic Criteria for Complex Regional Pain Syndrome |
Table 16-14: Objective Diagnostic Criteria Points for Complex Regional Pain Syndrome |
Table 16-15: Complex Regional Pain Syndrome (Type I) – Lower Extremity Impairments |
Table 16-16: Amputation Impairment |
Table 16-17: Functional History Net Modifier |
Table 16-18: Lesser Toe Impairments |
Table 16-19: Greater Toe Impairments |
Table 16-20: Hindfoot Motion Impairments |
Table 16-21: Ankle or Hindfoot Deformity Impairments |
Table 16-22: Ankle Motion Impairments |
Table 16-23: Knee Motion Impairments |
Table 16-24: Hip Motion Impairments – Lower Extremity Impairment |
Table 16-25: Range of Motion ICF Classification |
Chapter 17: The Spine and Pelvis |
Tables |
Table 17-1: Definition of Impairment Classes and Impairment Ranges |
Table 17-2: Cervical Spine Regional Grid: Spine Impairments |
Table 17-3: Thoracic Spine Regional Grid: Spine Impairments |
Table 17-4: Lumbar Spine Regional Grid: Spine Impairments |
Table 17-5: Adjustment Grid: Summary |
Table 17-6: Functional History Adjustment: Spine |
Table 17-7: Physical Examination Adjustment: Spine |
Table 17-8: Common Radicular Syndromes |
Table 17-9: Clinical Studies Adjustment: Spine |
Table 17-10: Methodology for Determining the Grade in an Impairment Class |
Table 17-11: Diagnosis-Based Impairment Grid: Pelvis |
Table 17-12: Functional History Adjustment: Pelvis |
Table 17-13: Physical Examination Adjustment: Pelvis |
Table 17-14: Clinical Studies Adjustment: Pelvis |
Table 17-A: PDQ Scoring |